APR 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/119916

Contents of this Issue


Page 61 of 82

April 2013 February 2011 below inflation, which is better than some fields," he said. Dr. Costarides asked his program's two glaucoma fellows, a resident who has selected glaucoma and a senior resident matched in a glaucoma fellowship program, why they chose the subspecialty. "There are various reasons," he said. "I think one of them is that there is more opportunity in glaucoma than there was demographically. I think there are better jobs out there and the ability to choose where you live. I think people have seen the value in doing a glaucoma fellowship in the sense that it's very good training, even if you want to do general ophthalmology, since there are so many glaucoma patients and many that are managed in general practices. The fellowship will clearly improve your ability to manage these patients. And many general ophthalmologists are not comfortable doing glaucoma surgery." Drs. Costarides, Gedde, and Rhee all said that the chronicity of care could be another reason residents are attracted to the subspecialty. Glaucoma specialists can see patients over 30+ years, often their entire careers. They must be emotional healers, understanding the full impact of the loss of vision. That role should not be taken lightly, Dr. Rhee said, and is an important aspect to the subspecialty. "[Glaucoma specialists] stand in the face of blindness," he said. "We stand in front of death of the eye, death of the ganglion cell, and we say, 'No, I am going to stop you. I am not going to let you take this person.' Unfortunately, I say that with every patient, and the other side wins far too often. But the point is that we are treating a disease in which if we are not here, patients will go blind or lose vision. We make a big difference. For those of us who choose it, I think we love it because we're proud of that." EW Reference Gedde SJ, Budenz DL, Haft P, Lee Y, Quigley HA. Factors affecting the decision to pursue glaucoma fellowship training. J Glaucoma. 2007;16(1):81-87. Editors' note: Dr. Costarides has financial interests with Glaukos (Laguna Hills, Calif). Drs. Gedde and Rhee have no financial interests related to this article. Contact information Costarides: a.costarides@emoryhealthcare.org EW GLAUCOMA 59 Gedde: 305-326-6435, sgedde@med.miami.edu Rhee: 617-573-3670, douglas_rhee@meei.harvard.edu THE 1960S CALLED. THEY WANT THEIR FILTRATION SURGERY BACK. It's time for a change. Discover Lumenal Control. The EX-PRESS® Glaucoma Filtration Device eliminates one of the most critical surgical variables. By standardizing the lumenal structure through which aqueous humor fows, you get consistent, predictable fltration. © 2013 Novartis 2/13 EXP13042JAD AlconSurgical.com CAUTION: Federal law restricts this device to sale by or on the order of a physician. INDICATION: The EX-PRESS® Glaucoma Filtration Device is intended to reduce intraocular pressure in glaucoma patients where medical and conventional surgical treatments have failed. GUIDANCE REGARDING THE SELECTION OF THE APPROPRIATE VERSION: Prior clinical studies were not designed to compare between the various versions of the EX-PRESS® Glaucoma Filtration Device. The selection of the appropriate version is according to the doctor's discretion. CONTRAINDICATIONS: The use of this device is contraindicated if one or more of the following conditions exist: t1SFTFODFPGPDVMBSEJTFBTFTVDIBTVWFJUJT PDVMBSJOGFDUJPO TFWFSFESZFZF TFWFSFCMFQIBSJUJT t1SFFYJTUJOHPDVMBSPSTZTUFNJDQBUIPMPHZUIBU JOUIFPQJOJPOPGUIFTVSHFPO JTMJLFMZUPDBVTFQPTUPQFSBUJWFDPNQMJDBUJPOTGPMMPXJOHJNQMBOUBUJPOPGUIFEFWJDF t1BUJFOUTEJBHOPTFEXJUIBOHMFDMPTVSFHMBVDPNB WARNINGS/PRECAUTIONS: t5IFTVSHFPOTIPVMECFGBNJMJBSXJUIUIFJOTUSVDUJPOTGPSVTF t5IFJOUFHSJUZPGUIFQBDLBHFTIPVMECFFYBNJOFEQSJPSUPVTFBOEUIFEFWJDFTIPVMEOPUCFVTFEJGUIFQBDLBHFJTEBNBHFEBOETUFSJMJUZJTDPNQSPNJTFE t5IJTEFWJDFJTGPSTJOHMFVTFPOMZ t.3*PGUIFIFBEJTQFSNJUUFE IPXFWFSOPUSFDPNNFOEFE JOUIFö STUUXPXFFLTQPTUJNQMBOUBUJPO ATTENTION:3FGFSFODFUIF%JSFDUJPOTGPS6TFMBCFMJOHGPSBDPNQMFUFMJTUJOHPGJOEJDBUJPOT XBSOJOHT QSFDBVUJPOT DPNQMJDBUJPOTBOEBEWFSTFFWFOUT

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - APR 2013